TECH Downgraded
Stephens & Co. downgrades Bio-Techne to Equal-Weight and raises price target to $73
Stephens & Co. analyst Steven Etoch downgrades Bio-Techne (NASDAQ: TECH ) from Overweight to Equal-Weight and raises the price target from $68 to $73.